• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1和kelch 13基因在尼日利亚阿库雷5岁及以下儿童中的分布情况。

1 and kelch 13 genes distribution among children that are 5 years and below in Akure, Nigeria.

作者信息

Afolabi Olajide Joseph, Oluwafemi Olubanke Rosena, Oniya Mobolanle Oladipo

机构信息

Parasitology and Public Health Unit, Department of Biology, Federal University of Technology, Akure, Ondo State Nigeria.

Department of Pediatrics, Mother and Child Hospital, Akure, Ondo State Nigeria.

出版信息

J Parasit Dis. 2023 Mar;47(1):59-67. doi: 10.1007/s12639-022-01538-7. Epub 2022 Oct 17.

DOI:10.1007/s12639-022-01538-7
PMID:36910307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9998786/
Abstract

Malaria parasite resistant to drugs has been a major barrier to effective treatment of malaria. Therefore, the study aimed to evaluate the distribution resistant Kelch protein gene on chromosome 13 (Kelch 13) and multidrug resistant () mutant genes among children aged five years and below who attended Mother and Child Hospital, Akure, Nigeria. Thin and thick smears were prepared from the blood collected aseptically through venepuncture from five hundred (500) children. Structured questionnaires were used to obtain demographic data from the respondents. Two hundred malaria positive samples were randomly selected from the 500 samples for PCR analysis to detect and mutant genes. The results showed that of the 500 respondents, 288 (57.6%) were males while 21 (42.4%) were females. Pfmdr1distribution include: mixed group (mutant/wild) 38.5%, mutant gene 35.5%, wild gene 20.5% and the resistant genes were absent in 5.5% of the infected children. The mixed group of gene was higher among infants (51.9%), children with birth order 4 (60.0%) and children that have blood group B (51.3%), however, there is no significant difference in the distribution of between gender (χ2 = 0.634, df = 1,  > 0.05). There was a point mutation in the codon position 557 where the amino acid Alanine was replaced by Serine in the The presence of mutant genes and point mutation in the gene of among children, calls for development of innovative drugs targeted on these resistant strains.

摘要

耐药物的疟原虫一直是有效治疗疟疾的主要障碍。因此,本研究旨在评估尼日利亚阿库雷州妇幼医院5岁及以下儿童中13号染色体上的抗药凯尔希蛋白基因(Kelch 13)和多药耐药()突变基因的分布情况。通过静脉穿刺无菌采集500名儿童的血液,制备厚薄血涂片。使用结构化问卷从受访者那里获取人口统计学数据。从500个样本中随机选取200个疟疾阳性样本进行PCR分析,以检测和突变基因。结果显示,在500名受访者中,288名(57.6%)为男性,212名(42.4%)为女性。Pfmdr1分布情况如下:混合组(突变体/野生型)38.5%,突变基因35.5%,野生基因20.5%,5.5%的感染儿童中不存在耐药基因。基因的混合组在婴儿中比例较高(51.9%),在出生顺序为4的儿童中(60.0%)以及血型为B的儿童中(51.3%),然而,基因在性别之间的分布没有显著差异(χ2 = 0.634,自由度 = 1,P > 0.05)。在密码子位置557处存在点突变,其中丙氨酸被丝氨酸取代。儿童中存在突变基因和基因的点突变,这就需要开发针对这些耐药菌株的创新药物。

相似文献

1
1 and kelch 13 genes distribution among children that are 5 years and below in Akure, Nigeria.1和kelch 13基因在尼日利亚阿库雷5岁及以下儿童中的分布情况。
J Parasit Dis. 2023 Mar;47(1):59-67. doi: 10.1007/s12639-022-01538-7. Epub 2022 Oct 17.
2
Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria.中非、西非和东非重症疟疾儿童抗疟药物耐药性的分子标志物
Malar J. 2017 May 23;16(1):217. doi: 10.1186/s12936-017-1868-y.
3
Efficacy of Artemether-Lumefantrine on various and genes isolated in Ghana.蒿甲醚-本芴醇对在加纳分离出的各种[具体内容缺失]和基因的疗效。
Parasite Epidemiol Control. 2020 Oct 26;11:e00190. doi: 10.1016/j.parepi.2020.e00190. eCollection 2020 Nov.
4
Mutations in Pfcrt and Pfmdr1 genes of Plasmodium falciparum isolates from two sites in Northcentral and Southwest Nigeria.来自尼日利亚中北部和西南部两个地点的恶性疟原虫分离株的Pfcrt和Pfmdr1基因中的突变。
Infect Genet Evol. 2021 Nov;95:105042. doi: 10.1016/j.meegid.2021.105042. Epub 2021 Aug 19.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Rare mutations in Pfmdr1 gene of Plasmodium falciparum detected in clinical isolates from patients treated with anti-malarial drug in Nigeria.在尼日利亚接受抗疟药物治疗的患者的临床分离株中检测到 Pfmdr1 基因的罕见突变。
Malar J. 2019 Sep 18;18(1):319. doi: 10.1186/s12936-019-2947-z.
7
Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.在尼日利亚拉各斯,氯喹作为一线抗疟药物更换四年后,患单纯性疟疾儿童中恶性疟原虫耐氯喹单倍型的持续存在情况。
Diagn Pathol. 2015 Apr 28;10:41. doi: 10.1186/s13000-015-0276-2.
8
Prevalence of mutations in Plasmodium falciparum genes associated with resistance to different antimalarial drugs in Nyando, Kisumu County in Kenya.肯尼亚基苏木县尼亚永地区与不同抗疟药物耐药性相关的疟原虫基因突变流行情况。
Infect Genet Evol. 2020 Mar;78:104121. doi: 10.1016/j.meegid.2019.104121. Epub 2019 Nov 19.
9
Molecular surveillance of pfcrt, pfmdr1 and pfk13-propeller mutations in Plasmodium falciparum isolates imported from Africa to China.从非洲输入中国的恶性疟原虫分离株中 pfcrt、pfmdr1 和 pfk13 螺旋桨结构域突变的分子监测
Malar J. 2021 Feb 6;20(1):73. doi: 10.1186/s12936-021-03613-5.
10
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.青蒿琥酯-咯萘啶治疗无并发症疟疾的疗效和安全性以及在坦桑尼亚大陆使用青蒿素为基础的联合疗法十年后 Pfk13 和 Pfmdr1 多态性的流行情况。
Malar J. 2019 Mar 21;18(1):88. doi: 10.1186/s12936-019-2730-1.

引用本文的文献

1
Emerging Plasmodium falciparum K13 gene mutation to artemisinin-based combination therapies and partner drugs among malaria-infected population in sub-Saharan Africa.撒哈拉以南非洲疟疾感染人群中恶性疟原虫K13基因对青蒿素联合疗法及相关药物的新出现突变
Parasites Hosts Dis. 2025 May;63(2):109-122. doi: 10.3347/PHD.24053. Epub 2025 May 26.
2
Polymorphisms in Pfkelch13 domains before and after the introduction of artemisinin-based combination therapy in Southwest Nigeria.在尼日利亚西南部引入以青蒿素为基础的联合疗法前后,Pfkelch13结构域中的多态性
PLoS One. 2025 Mar 31;20(3):e0316479. doi: 10.1371/journal.pone.0316479. eCollection 2025.

本文引用的文献

1
Distribution of and chloroquine drug resistance alleles in north-western Nigeria.尼日利亚西北部氯喹耐药等位基因的分布情况。 (注:原文中“and”前少了一个单词,推测可能是某种药物名称,比如“某药和氯喹”,这里暂且按照正常逻辑翻译)
Malariaworld J. 2017 Aug 1;8:15. eCollection 2017.
2
Pyronaridine-artesunate Efficacy and Safety in Uncomplicated Plasmodium falciparum Malaria in Areas of Artemisinin-resistant Falciparum in Viet Nam (2017-2018).吡喹酮-青蒿琥酯治疗越南耐青蒿素地区无并发症恶性疟原虫感染的疗效和安全性(2017-2018 年)。
Clin Infect Dis. 2020 May 6;70(10):2187-2195. doi: 10.1093/cid/ciz580.
3
Asymptomatic malaria infections and Pfmdr1 mutations in an endemic area of Nigeria.尼日利亚流行地区无症状疟疾感染与 Pfmdr1 突变。
Malar J. 2019 Jun 27;18(1):218. doi: 10.1186/s12936-019-2833-8.
4
Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015.2015 年莫桑比克疟原虫的耐药多态性和拷贝数。
Emerg Infect Dis. 2018 Jan;24(1):40-48. doi: 10.3201/eid2401.170864.
5
Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.在尼日利亚拉各斯,氯喹作为一线抗疟药物更换四年后,患单纯性疟疾儿童中恶性疟原虫耐氯喹单倍型的持续存在情况。
Diagn Pathol. 2015 Apr 28;10:41. doi: 10.1186/s13000-015-0276-2.
6
Novel mutations in K13 propeller gene of artemisinin-resistant Plasmodium falciparum.青蒿素耐药恶性疟原虫K13螺旋桨基因的新型突变
Emerg Infect Dis. 2015 Mar;21(3):490-2. doi: 10.3201/eid2103.140898.
7
Spread of artemisinin resistance in Plasmodium falciparum malaria.疟原虫青蒿素耐药性的传播。
N Engl J Med. 2014 Jul 31;371(5):411-23. doi: 10.1056/NEJMoa1314981.
8
Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene haplotype SVMNT in P. falciparum malaria in India.恶性疟原虫氯喹抗性转运蛋白(Pfcrt)基因单倍型SVMNT在印度恶性疟原虫疟疾中的广泛出现。
Am J Trop Med Hyg. 2004 Mar;70(3):256-9.
9
Two patients with falciparum malaria and poor in vivo responses to artesunate.两名患有恶性疟且对青蒿琥酯体内反应不佳的患者。
Trans R Soc Trop Med Hyg. 1998 Nov-Dec;92(6):668-9. doi: 10.1016/s0035-9203(98)90807-0.